Buy, Sell Or Hold: HDFC Bank, Vodafone Idea, Poonwalla Fincorp, Emcure Pharma | Ask Profit
HDFC Bank left its position unchanged.
· NDTV Profit
Market experts shared their insights on fundamentals and technical levels for key stocks.
The analysis
Against that, the stock is -0.6% on the day at ₹703.00, and has returned -14.3% over three months. It sits 30% below its 52-week high, which means a good deal of bad news was already in the price. The banks sector has moved -4.9% over the same period, so HDFC Bank is running 9.4 points behind its peers.
For HDFC Bank, the question is how much of this is already reflected in the price and how much re-rates the banks peer set alongside it.
Market context
- The company directly in focus is HDFCBANK.
- Sector exposure: Banks, Telecom & Media, Pharma & Healthcare.
In this story
Related coverage
TCS, HDFC Life, Cipla - Which stock to buy and sell? Jigar Patel of Anand Rathi suggests strategy - Target, stop loss
Earnings Tracker: HDFC Bank, HCL Tech, Wipro among 129 companies set to report Q2 results this week
Vodafone Idea zooms 12% after FPO sees 6x subscription; focus shifts to allotment, listing
Indus Towers gains 4% after CLSA upgrade to #39;buy#39; on Voda Idea FPO
Top NBFC stocks to buy: HDFC Sec recommend 15 shares to add in portfolio ahead of Q2 results | Check rating, target